Mini-invasive surgery for lung cancer and heart rhythm changes
Part of Cancer, Heart & circulation, Lungs & breathing clinical trials.
This study looks at how lung cancer surgery affects the heart’s electrical signals and stress response, using heart tracing tests (ECG) around the time of surgery. It may help doctors better understand and monitor heart risks in people having curative, minimally invasive lung cancer surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18+) scheduled for planned lung cancer surgery
- Your lung cancer surgery is meant to cure the cancer (curative intent)
- Your surgical plan is for minimally invasive (mini-invasive) surgery
- You’re willing to take part and follow the study instructions
- You are not in another medical study at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart MRI with a stress medication to see how well the right side of the heart pumps after lung or upper digestive surgery. It may help doctors understand heart recovery after these operations.
This trial tests a new device called CellFX that uses nanosecond pulsed field ablation to treat atrial fibrillation during open-heart surgery. It may help you if you already need heart surgery and also have AFib.
This study checks if a simple test of your heart and breathing before chest surgery can help predict problems after the operation. It looks at people having surgery for lung, esophagus, stomach, or chest tumors.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
This study looks at whether an added heart device approach around the time of planned open-heart surgery can help treat non-paroxysmal atrial fibrillation (AF), a long-lasting irregular heartbeat. It may help lower ongoing AF burden in people who also need non-emergency heart surgery.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.